LVADs: Thoratec study a Roadmap to lower-risk patients? – MassDevice

One-year results from Thoratec‘s (NSDQ:THOR) Roadmap trial, revealed last week, could point the way toward the use of implantable heart pumps in less-sick heart failure patients.